A Population-Based Study on the Epidemiology of Functional Gastrointestinal Disorders in Young Children

Ashish Chogle1, Carlos A Velasco-Benitez2, Ilan J Koppen3

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Orange County, Orange, CA.

The Journal of Pediatrics
|October 12, 2016
PubMed

Insights

Functional gastrointestinal disorders (FGIDs) affect 40.5% of young children in Colombia. Functional constipation is the most common FGID in both infants and older children, with higher prevalence in certain family structures.

Area of Science:

  • Pediatric Gastroenterology
  • Public Health Epidemiology

Background:

  • Functional gastrointestinal disorders (FGIDs) are prevalent conditions in pediatric populations worldwide.
  • Understanding the epidemiology of FGIDs in diverse geographic regions is crucial for targeted interventions.

Purpose of the Study:

  • To determine the prevalence of FGIDs in Colombian children aged 0-48 months using Rome III criteria.
  • To identify specific FGIDs and associated demographic factors in this population.

Main Methods:

  • A multicity cross-sectional study was conducted with 1231 participants.
  • The Spanish version of the Questionnaire on Pediatric Gastrointestinal Symptoms for Infants & Toddlers was administered to parents.
  • Children with organic medical diseases were excluded from the analysis.

Main Results:

  • 40.5% of children (n=480) were diagnosed with at least one FGID.
  • Functional constipation was the most prevalent FGID in both infants (16.1%) and children aged 13-48 months (26.8%).
  • FGID prevalence was higher in first-born children, only children, and those with divorced or separated parents.

Conclusions:

  • FGIDs are common in children under four years old in Colombia.
  • Functional constipation is a significant issue across different pediatric age groups.
  • Family structure may be associated with the prevalence of FGIDs in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
626
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
998
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.6K